Pricey cancer genome project struggles with sample shortage

Waltz, Emily
April 2007
Nature Medicine;Apr2007, Vol. 13 Issue 4, p391
Academic Journal
The article reports on the goal of the Cancer Genome Atlas (CGA) to examine tumor samples for mutations that promote cancer. The CGA planned to analyze genes from lung, brain and ovarian tumors. It would then develop targeted cancer treatments and catalog the genetic changes in samples which represent 100 types of cancer.


Related Articles

  • Big science: The cancer genome challenge. Ledford, Heidi // Nature;4/15/2010, Vol. 464 Issue 7291, p972 

    The article explores challenges faced by researchers as they search for meaning on data of genome sequences of tumours in the U.S. It notes the effort of the International Cancer Genome Consortium (ICGC) to sequence 500 tumours from each of 50 cancers in 2008. It mentions the arguments of some...

  • Old dog, new tricks. Brooks, Michael // New Statesman;2/7/2014, Vol. 143 Issue 5196, p15 

    The article looks at cancer research as of 2014, discussing a study reported in the journal "Science" on the genome of a fossil dog that was infected with the canine transmissible venereal tumour (CTVT). The author notes that CTVT is prevalent in dogs today but is relatively harmless. He says...

  • Large-Scale Survey Of Cancer Gene Mutations.  // Nutrition Health Review: The Consumer's Medical Journal;2007, Issue 98, p4 

    The article reports that a study led by researchers in the U.S. provided the first demonstration of a practical method of screening tumors for cancer-related gene abnormalities. Levi Garraway from Dana-Farber Cancer Institute explained that cancer is a disease of the genome. The researchers...

  • Oral Presentations 6.  // British Journal of Cancer;7/1/2004 Supplement, Vol. 91, pS18 

    The article presents several studies related to the treatment of various diseases. It states a sensitive and reproducible method for identification of radiation-induced mutations and the implications for radiation treatment &an&protection. The induction of tumour hypoxia by vascular disrupting...

  • The RAS oncogene induces genomic instability in thyroid PCCL3 cells via the MAPK pathway. Saavedra, Harold I; Knauf, Jeffrey A; Shirokawa, Jill M; Wang, Jianwei; Ouyang, Bin; Elisei, Rosella; Stambrook, Peter J; Fagin, James A // Oncogene;8/10/2000, Vol. 19 Issue 34, p3948 

    Activating mutations of RAS are thought to be early events in the evolution of thyroid follicular neoplasms. We used a doxycycline-inducible expression system to explore the acute effects of H-RASV12 on genomic stability in thyroid PCCL3 cells. At 2–3 days (first or second cell cycle)...

  • Mitochondrial mutagenesis induced by tumor-specific radiation bystander effects. Gorman, Sheeona; Fox, Edward; O'Donoghue, Diarmuid; Sheahan, Kieran; Hyland, John; Mulcahy, Hugh; Loeb, Lawrence A.; O'Sullivan, Jacintha // Journal of Molecular Medicine;Jul2010, Vol. 88 Issue 7, p701 

    The radiation bystander effect is a cellular process whereby cells not directly exposed to radiation display cellular alterations similar to directly irradiated cells. Cellular targets including mitochondria have been postulated to play a significant role in this process. In this study, we...

  • Genome-wide association studies and genetic architecture of common human diseases. Montgomery, Grant W. // BMC Proceedings;2011 Supplement 2, Vol. 5 Issue Suppl 2, pS16 

    Genome-wide association scans provide the first successful method to identify genetic variation contributing to risk for common complex disease. Progress in identifying genes associated with melanoma show complex relationships between genes for pigmentation and the development of melanoma. Novel...

  • Tumor Heterogeneity and Personalized Medicine. Longo, Dan L. // New England Journal of Medicine;3/8/2012, Vol. 366 Issue 10, p956 

    The article discusses research that maps out the heterogeneity within a single tumor. The study reveals that two-thirds of the mutations found in single biopsies were not uniformly detectable throughout all the sampled regions of the same patient's tumor. As such, a single tumor biopsy cannot be...

  • Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing. Gerlinger, Marco; Horswell, Stuart; Larkin, James; Rowan, Andrew J; Salm, Max P; Varela, Ignacio; Fisher, Rosalie; McGranahan, Nicholas; Matthews, Nicholas; Santos, Claudio R; Martinez, Pierre; Phillimore, Benjamin; Begum, Sharmin; Rabinowitz, Adam; Spencer-Dene, Bradley; Gulati, Sakshi; Bates, Paul A; Stamp, Gordon; Pickering, Lisa; Gore, Martin // Nature Genetics;Mar2014, Vol. 46 Issue 3, p225 

    Clear cell renal carcinomas (ccRCCs) can display intratumor heterogeneity (ITH). We applied multiregion exome sequencing (M-seq) to resolve the genetic architecture and evolutionary histories of ten ccRCCs. Ultra-deep sequencing identified ITH in all cases. We found that 73-75% of identified...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics